Article
Analysis of flavin-containing monooxygenase 3 genotype data in populations administered the anti-schizophrenia agent olanzapine.
Drug metabolism letters - 1 Apr 2008
Cashman John R, Zhang Jun, Nelson Matthew R, Braun Andreas
Abstract excerpt
Flavin-containing monooxygenase 3 (FMO3) genotype data for European-, Latin-, African- and Asian-American schizophrenia patients administered olanzapine were compared to age-, gender-, and race/ethnicity-matched controls. Single nucleotide polymorphisms and haplotypes associated with case-control status was undertaken to determine the potential role of FMO3 in olanzapine therapeutic response. The relationship...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.